Withaferin A

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameWithaferin A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUofL Health
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Louisville
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A